Keyphrases
Multiple Myeloma
100%
End-stage Renal Failure
100%
Continuous Ambulatory Peritoneal Dialysis
100%
Peritonitis
80%
Chemotherapy
40%
Neutropenia
40%
Hemodialysis
40%
Myeloma
40%
Septicemia
40%
Hematological Response
40%
Non-responders
20%
Bleeding
20%
Staphylococcus Aureus
20%
High Incidence
20%
Bone Marrow
20%
Poor Prognosis
20%
Central Nervous System
20%
Gastrointestinal Tract
20%
Thrombocytopenia
20%
Catheter
20%
Dialysis
20%
Alkylating Agents
20%
Gram-positive
20%
Antibiotic Therapy
20%
Agent-based
20%
Fluid Control
20%
Preferred Mode
20%
Subclavian Vein
20%
Chronic Dialysis
20%
Blood Transfusion Requirement
20%
Supression
20%
Intraperitoneal Antibiotics
20%
Medicine and Dentistry
End Stage Renal Disease
100%
Multiple Myeloma
100%
Continuous Ambulatory Peritoneal Dialysis
100%
Peritonitis
80%
Neutropenia
40%
Hemodialysis
40%
Myeloma
40%
Septicemia
40%
Antibiotic Therapy
20%
Bleeding
20%
Blood Transfusion
20%
Gastrointestinal Tract
20%
Thrombocytopenia
20%
Central Nervous System
20%
Staphylococcus Aureus
20%
Alkylating Antineoplastic Agent
20%
Subclavian Vein
20%
Pharmacology, Toxicology and Pharmaceutical Science
End Stage Renal Disease
100%
Multiple Myeloma
100%
Peritonitis
100%
Chemotherapy
50%
Hemodialysis
50%
Neutropenia
50%
Myeloma
50%
Septicemia
50%
Bleeding
25%
Staphylococcus Aureus
25%
Alkylating Agent
25%
Antibiotic Therapy
25%
Thrombocytopenia
25%
Nursing and Health Professions
Continuous Ambulatory Peritoneal Dialysis
100%
End Stage Renal Disease
100%
Multiple Myeloma
100%
Peritonitis
80%
Hemodialysis
40%
Neutropenia
40%
Myeloma
40%
Septicemia
40%
Bleeding
20%
Antibiotic Therapy
20%
Blood Transfusion
20%
Thrombocytopenia
20%
Alkylating Agent
20%
Subclavian Vein Catheter
20%
Immunology and Microbiology
Multiple Myeloma
100%
Continuous Ambulatory Peritoneal Dialysis
100%
Peritonitis
80%
Hemodialysis
40%
Staphylococcus Aureus
20%
Central Nervous System
20%
Gastrointestinal Tract
20%
Blood Transfusion
20%
Subclavian Vein
20%